Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CHANGE & IMPACT, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to improving access to healthcare and expanding services and resources for those who have a speech impediment; Issues related to intervention research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOP THE RAIL MERGER, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Source: Senate LDA
Engaged with lawmakers on the impacts of the proposed merger between Union Pacific and Norfolk Southern railroads.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), White House Office
HIGHLAND ELECTRIC FLEETS via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to federal clean school bus programs.
Issues related to federal clean school bus programs.
Issues related to electric grid infrastructure.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STOP THE RAIL MERGER, INC. via CGCN GROUP, LLC
2026 · second_quarter · RR
Engage with lawmakers on opposing the merger of Union Pacific and Norfolk Southern railroads.
HIGHLAND ELECTRIC FLEETS via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to federal clean school bus programs.
Issues related to electric grid infrastructure.
Issues related to federal clean school bus programs.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHANGE & IMPACT, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to improving access to healthcare and expanding services and resources for those who have a speech impediment; Issues related to intervention research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE